chrX-11298569-C-A
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_001142.2(AMELX):c.166C>A(p.Pro56Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P56L) has been classified as Pathogenic.
Frequency
Consequence
NM_001142.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AMELX | NM_001142.2 | c.166C>A | p.Pro56Thr | missense_variant | 5/6 | ENST00000380714.7 | |
ARHGAP6 | NM_013427.3 | c.589-43862G>T | intron_variant | ENST00000337414.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AMELX | ENST00000380714.7 | c.166C>A | p.Pro56Thr | missense_variant | 5/6 | 1 | NM_001142.2 | P1 | |
ARHGAP6 | ENST00000337414.9 | c.589-43862G>T | intron_variant | 1 | NM_013427.3 | P2 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
AMELX-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 27, 2024 | The AMELX c.208C>A variant is predicted to result in the amino acid substitution p.Pro70Thr. This variant, alternatively referred to as P41T in the literature and c.166C>A (p.Pro56Thr) in ClinVar, has been reported to segregate in multiple families with amelogenesis imperfecta (AI) (Collier et al. 1997. PubMed ID: 9188994; Ravassipour et al. 2000. PubMed ID: 11005731; Hart et al. 2000. PubMed ID: 10669095; Chan et al. 2011. PubMed ID: 22243262). Affected individuals present with a distinct and consistent hypomaturation form of AI. Functional studies demonstrate protein instability and decreased binding affinity for amelogenin (Tanimoto et al. 2008. PubMed ID: 18434575; Lakshminarayanan et al. 2010. PubMed ID: 20929860). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 08, 2024 | Published functional studies demonstrate a damaging effect causing decreased degradation of amelogenin by MMP20 resulting in altered mineralization (PMID: 21081224, 18434575, 31239344); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 18390542, 11922869, 22243262, 20929860, 18434575, 17384027, 20923441, 16674655, 10669095, 11005731, 15892947, 21127961, 12952177, 16838342, 21597265, 9188994, 16674656, 31239344, 21081224) - |
Amelogenesis imperfecta type 1E Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2002 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at